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Abstract
Background: Alterations in gene expression in the suicide brain have been reported and for several genes DNA
methylation as an epigenetic regulator is thought to play a role. rRNA genes, that encode ribosomal RNA, are the backbone
of the protein synthesis machinery and levels of rRNA gene promoter methylation determine rRNA transcription.
Methodology/Principal Findings: We test here by sodium bisulfite mapping of the rRNA promoter and quantitative real-
time PCR of rRNA expression the hypothesis that epigenetic differences in critical loci in the brain are involved in the
pathophysiology of suicide. Suicide subjects in this study were selected for a history of early childhood neglect/abuse,
which is associated with decreased hippocampal volume and cognitive impairments. rRNA was significantly
hypermethylated throughout the promoter and 59 regulatory region in the brain of suicide subjects, consistent with
reduced rRNA expression in the hippocampus. This difference in rRNA methylation was not evident in the cerebellum and
occurred in the absence of genome-wide changes in methylation, as assessed by nearest neighbor.
Conclusions/Significance: This is the first study to show aberrant regulation of the protein synthesis machinery in the
suicide brain. The data implicate the epigenetic modulation of rRNA in the pathophysiology of suicide.
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Introduction
Suicide is a leading cause of death, particularly in males [1,2].
Although many suicide subjects have a diagnosable psychiatric
illness, most persons with a psychiatric disorder never attempt
suicide [2]. Suicidal behavior aggregates in families [1], and
studies of twins show that monozygotic individuals have a greater
concordance for suicide completion and suicide attempts com-
pared to dizygotic individuals [2–4]. Non-genetic familial factors,
including a history of abuse or neglect during childhood, are also
risk factors for suicidal behavior [5,6]. Similarly, childhood abuse
is associated with an increased risk for psychopathology [7,8] and
altered neural development [9].
Several lines of evidence suggest that changes in gene expression
in the brain occur in the context of psychiatric disorders and
suicide [10–15]. Alterations in gene regulation can be caused by
epigenetic programming of gene expression in response to
environmental exposure, including social and physical adversity
[16]. The genome is epigenetically programmed by changes in the
chromatin state and by a pattern of modification of the DNA
molecule itself through methylation [17]. DNA methylation is a
stable epigenetic mark associated with long-lasting silencing of
gene expression [18]. In rodents, genes responsive to differences in
the quality of maternal care early in life are altered through
epigenetic mechanisms [19,20]. In the human brain, aberrant
DNA methylation of specific genes also occurs in the context of
psychiatric disorders [21–26]. Decreased expression of ribosomal
RNA (rRNA), a bottleneck gene for protein production in the cell,
occurs in patients with mild cognitive impairment and early
Alzheimer’s disease [27,28].
DNA methylation can regulate gene expression in two ways.
One is site-specific methylation, involving direct interference with
the binding of transcription factors [29]. The second is site-
independent promoter-wide methylation, attracting methylated
DNA binding proteins and leading to an inactive chromatin
structure. In the latter case, the density of methylated CpGs
determines the extent of gene silencing [30]. Both mechanisms can
regulate rRNA expression. Previous work in cultured mouse cells
indicated that rRNA is regulated by methylation of a single CpG
dinucleotide at position 2133 residing at the upstream control
element (UCE) [31]. In human cell culture, the transcriptionally
active fraction of rRNA promoters associated with RNA
polymerase I (pol I) is completely unmethylated whereas the
fraction not associated with pol I is almost completely methylated
[32], thus determining transcription by defining the fraction of
unmethylated rRNA. Mouse and human rRNA promoters show
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mouse and 26–28 in the human [31,33]). Thus, although in both
species complete methylation of CpGs in the promoters charac-
terizes inactive alleles, the number of CpGs involved is different
suggesting a different mode of regulation by DNA methylation.
In the present study, we tested the hypothesis that rRNA in the
human hippocampus of suicide subjects with a history of
childhood abuse or severe neglect and controls who died suddenly
of unrelated causes without a history of childhood abuse or severe
neglect is differentially methylated and expressed. Within the
genome there are over 400 copies of the rRNA gene, encoding a
large pre-rRNA transcriptional unit (45S) whose expression is
tightly regulated by methylation [31–34]. We particularly
examined the core promoter region and UCE of rRNA because
it is involved in the regulation of all pol I transcribed copies of
rRNA by methylation [33]. Our strategy was to sample the
average methylation pattern of the rRNA promoter at single
nucleotide resolution to determine CpG site specificity in the
regulation of rRNA gene expression in the brains of suicide
subjects and controls. The results implicate the epigenetic
modulation of rRNA in the pathophysiology of suicide.
Results
The subject characteristics are presented in Table 1. There
were no significant differences in post-mortem interval (PMI),
brain pH, or age between suicide subjects and controls (P’s.0.05).
Genotyping of the rRNA promoter
Because alterations in rRNA function may occur due to both
genetic and epigenetic differences, the rRNA promoter region
from each suicide subject and control was sequenced. No sequence
variants were seen among subjects (Fig. 1; also see Fig. S1).
When the sequence was compared to the published reference
sequence for the rRNA promoter region (Genebank accession
number: U13369) a few discrepancies were discovered. Notably,
two CpG dinucleotides were not found in the sequenced DNA
(Fig. 1). One CpG dinucleotide between the CpG dinucleotides in
positions 2108 and 2103 was simply absent, and a second just
upstream of the CpG dinucleotide in position 23 was found to be a
C/T nucleotide substitution. Thus, of the 28 CpG dinucleotides in
the published sequence, 26 CpG dinucleotides were present in the
samples. As all subjects in our study were of French-Canadian
origin, a population with a well established founder effect [35], it is
Table 1. Demographic characteristics and psychiatric
diagnoses.
1
Suicide Control
Male/Female 18/0 12/0
Age (years) 34 6 93 6 6 12
PMI (hours) 24 6 5.3 23 6 5.9
pH 6.4 6 0.4 6.5 6 0.2
Childhood Abuse/Neglect 18/18 100% 0/12 0%
Mood Disorder 14/18 78% 3/12 25%
Alcohol/Drug Abuse Disorder 12/18 67% 5/12 42%
Anxiety Disorder 3/18 17% 1/12 8%
The values are mean 6 SD.
1The number of subjects in each group represents the total number of subjects
used for methylation and expression analysis. Additional subjects used for
expression analysis did not differ from the other subjects in any of the listed
measures (see Materials and Methods for details; P’s.0.05).
doi:10.1371/journal.pone.0002085.t001
Figure 1. Genotyping of the rRNA promoter. The rRNA promoter sequence was identical for all suicide subjects and controls. The sequence
derived from genotyping is shown above the published rRNA sequence, indicating consensus sequences for primers used for sodium bisulfite
mapping (underline) and CpG dinucleotides (bold font), with locations marked relative to the transcription start site (arrow). Differences with the
published rRNA sequence, U13369, are highlighted in grey, and the base pair length of each sequence is listed on the right side.
doi:10.1371/journal.pone.0002085.g001
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regards to the reference sequence. For each subject, sequences
overlapping the region targeted by primers after bisulfite
conversion were identical to the published sequence, except for
the presence of a G/T conversion in the forward primer that was
present in all subjects, thus eliminating potential primer bias
between subjects in sodium bisulfite mapping.
The rRNA Promoter is Hypermethylated in the
Hippocampus of Suicide Subjects
DNA methylation can affect expression via specific methylation
of distinct CpG sites [29] and/or via regional site-independent
changes in the overall density of methylation [30]. Previous work
in cell culture on the state of human rRNA promoter methylation
showed regional differences in methylation between active and
inactive rRNA promoters [32]. To determine whether the pattern
of methylation of single nucleotides and/or the overall methylation
of rRNA differed between suicide subjects and controls, the rRNA
promoter was examined at single nucleotide resolution by sodium
bisulfite mapping (Fig. 2). The rRNA promoter was heavily
methylated throughout the promoter and 59 regulatory region in
the hippocampus of suicide subjects in comparison with that of
controls (F(1)=191.04, P,0.0001, Fig. 2, 3A). Twenty-one out of
26 CpG sites were significantly more methylated in suicide subjects
compared to controls, whereas no CpG was more methylated in
controls relative to suicide subjects (F(25)=11.01, P,0.001;
Fig. 3A). An analysis of the effect size for each CpG site revealed
that these 21 sites did not differ in the magnitude of the
methylation difference between groups at each CpG site
(P’s.0.05).
Figure 2. Sodium bisulfite mapping of the rRNA promoter in suicide subjects and controls. Twenty clones were sequenced for each
suicide subject (left side) and control (right side), from 2 to 3 independent PCR reactions. Each line represents one clone. Circles representing CpG
dinucleotides follow the 59 to 39 order of the rRNA promoter sequence for methylated CpG dinucleotides (filled circles), and unmethylated CpG
dinucleotides (open circles).
doi:10.1371/journal.pone.0002085.g002
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the suicide subjects, whereas control subjects showed a greater
number of hypomethylated clones (Fig. 3B). An analysis of the
regression slopes between groups revealed a significant (F(1)=7.33,
P,0.01) interaction between the number of methylated CpG sites
per clone for suicide subjects compared to controls. These data
indicate a dramatic increase in the ratio of methylated to
unmethylated clones among suicide subjects across most CpG sites.
To determine whether the state of methylation of specific CpG
methylationsites differed acrossthe rRNApromoterbetweensuicide
subjects and controls or whether all CpG sites differed similarly
between the two groups, the relationship between groups of the
average percentage of methylation for each CpG site was
investigated. There was a strong linear relationship between the
means of the two groups (R=0.92, P,0.00001; Fig. 4)d e m o n -
strating a similar difference in the state of methylation of all CpG
sites in between the groups. No single CpG site stood out as being
particularlydifferent betweenthegroupssuggesting nositeselectivity
of methylation in the rRNA of suicide subjects. Instead, the overall
level of methylation throughout the promoter and regulatory region
differed between the groups. These data showing a lack of site-
specificity are consistent with our recent analysis of the state of
methylation of rRNA genes in cultured cells [32].
Specificity of Hippocampal rRNA methylation by Analysis
of Cerebellum rRNA and Genome-Wide Methylation
To examine the anatomical specificity of the differences in
rRNA methylation between suicides and controls in the hippo-
campus, rRNA promoter methylation was examined in the
cerebellum, a region not primarily associated with psychopathol-
ogy. Individuals from the suicide subjects group who showed large
differences in hippocampal rRNA promoter methylation by
contrast to those in the control group (t(6)=4.12, P,0.01;
Fig. 5A) were selected to test whether these differences would
be conserved in another brain region. In contrast to the
hippocampus, there was no significant difference in the percentage
of methylated CpG sites between suicide subjects and controls in
the cerebellum (t(6)=0.55, P=0.6; Fig. 5B). There was no
significant correlation between levels of methylation in the
hippocampus and those in the cerebellum (R=0.11, P=0.78),
showing anatomical specificity in the hypermethylation of the
rRNA promoter in hippocampus of suicide subjects. The
interaction between the regression slopes for the number of
methylated CpG sites per clone was not significant (F(1)=0.26,
P=0.61; Fig. 5C), indicating that there was no difference in the
ratio of unmethylated to methylated clones between groups in the
cerebellum.
Figure 3. Hypermethylation of the rRNA promoter in suicide subjects relative to controls. (A) (above) Vertical lines indicate locations of
CpG dinucleotides on the rRNA promoter relative to the transcription start site, indicated with the solid arrow, with primer pairs used for bisulfite
mapping marked by dashed arrows. (below) Average percentage of methylation for each CpG site, for suicide subjects (N=13; black bars) and
controls (N=11; white bars). Data are expressed as mean 6 S.E.M. *, P,0.05; **, P,0.01; ***, P,0.001, measured by ANOVA. (B) Multiple regression
analysis of the number of methylated CpGs per clone and the number of clones shows a significant interaction between suicide subjects (20 clones6
13 subjects, N=260 total clones; filled circles) and controls (20 clones611 subjects, N=220 total clones; open circles). There are 26 circles per group,
as clones are grouped according to methylation status.
doi:10.1371/journal.pone.0002085.g003
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of the rRNA promoter in the hippocampus reflect genome-wide
differences in methylation between suicide subjects and controls,
nearest neighbor analysis of the overall percentage of methylated
cytosines was performed for each subject. Nearest neighbor
analysis revealed no significant difference between suicide subjects
and controls in the overall percentage of methylated cytosines
(t(22)=0.54, P=0.59), and there was no significant correlation
between the percentage of rRNA promoter methylation and
genome-wide methylation (R=0.07, P=0.78), revealing specific-
ity in the regulation of the rRNA promoter by methylation in the
suicide brain (Fig. 5D).
rRNA Methylation Does Not Vary With Psychiatric
Diagnoses
Next, the relationship between methylation and psychiatric
diagnoses was examined (Table 1). Mood disorders and substance
abuse disorders are risk factors for suicide and have also been
linked to alterations of DNA methylation in several genes
[24,25,36,37]. There were no significant differences within the
suicide subjects or the controls when the overall percentages of
rRNA methylation of those with mood disorders were compared
to those without mood disorders as well as among those with
substance abuse disorders compared to those without substance
abuse disorders (all P’s.0.05).
rRNA Expression is Downregulated in Suicide
Because it has been established in cell culture that methylation
of the rRNA promoter regulates the transcription of rRNA [31–
34], rRNA expression in suicide subjects and controls was
investigated. rRNA expression was significantly higher in controls
than in suicide subjects (t(23)=2.16, P,0.05; Fig. 6A). Correla-
tional analysis revealed a trend for a relationship between the
overall percentage of methylation and rRNA expression
(R=20.21, P.0.05; Fig. 6B), indicating that rRNA expression
may be regulated by methylation and additional epigenetic factors.
There was no relationship between and PMI, brain pH, or age
and rRNA expression (P’s.0.05).
Discussion
The data reveal evidence for DNA hypermethylation of the
rRNA promoter region in the hippocampus of suicide subjects
with histories of childhood abuse or severe neglect relative to
controls (victims of sudden, accidental death with no history of
abuse or neglect). Although our findings are largely based on
correlational studies indicating an association between psychopa-
thology and methylation, these data are consistent with growing
evidence suggesting that alterations in cytosine methylation
mediate biological processes associated with psychopathology [38].
Since DNA methylation is a highly stable mark, the bond
between a methyl group and cytosine ring being one of the most
stable chemical bonds [18], the differences in methylation are
unlikely to be a consequence of conditions immediately preceding
death or during the postmortem interval. No reaction which could
spontaneously demethylate 5-methylcytosine in DNA has ever
been described. Our data indicate that post mortem pH does not
affect DNA methylation (CE POM VD MJM MS and GT,
unpublished observations). Indeed, post-mortem interval, brain
pH, or age did not differ between suicide subjects and controls.
The increase in hippocampal rRNA promoter methylation
among suicide subjects appears to occur in the absence of obvious
site-specific effects on particular CpG sites. The results are
consistent with data in cell culture showing that transcriptionally
active rRNA promoters are completely unmethylated while
transcriptionally inactive molecules are completely methylated in
a promoter-wide manner without any obvious site selectivity [32].
In contrast to the situation in humans reported here and
previously reported in human cells in culture, the situation in
mouse is different. In the mouse, a site-specific change in
methylation is sufficient to mediate silencing of the rRNA
promoter [31].
Importantly, the changes in rRNA promoter methylation do not
reflect a genome-wide change in methylation, as nearest neighbor
analysis revealed no differences in overall levels of methylation in
suicide subjects relative to controls. Moreover, this difference in
the methylation of the rRNA promoter shows anatomical
specificity. When the rRNA methylation status for subjects with
large methylation differences in hippocampus was assessed in the
cerebellum, suicide subjects and controls showed similar levels of
rRNA methylation. In contrast to the hippocampus, the number
of methylated CpG sites observed per clone was similar between
suicide subjects and controls in the cerebellum. As a part of the
brain not primarily associated with neuroplastic changes influenc-
ing psychopathology, this result indicates that rRNA methylation
differences between the groups are specific to the hippocampus.
In addition to the difference in methylation, suicide subjects
showed impaired hippocampal rRNA expression compared to
controls. The decrease in gene expression was associated with
increased methylation of the rRNA promoter sequence, as
indicated by a trend for a linear correlation between the overall
percentage of methylation and gene expression. Although a trend
was evident, the results do not exclude other known epigenetic
mechanisms influencing rRNA gene expression. For example, in
Figure 4. Site-independent hypermethylation of the rRNA
promoter in suicide subjects. Positive correlation between suicide
and control rRNA promoter methylation percentage across CpG sites
(N=26), showing a conserved hypermethylation in suicide subjects
throughout the promoter region. Each data point is labeled with the
position of each CpG dinucleotide in the rRNA promoter, relative to the
transcription start site.
doi:10.1371/journal.pone.0002085.g004
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status of histone 4 influences rRNA expression [31,39].
In this study, we selected suicide subjects with a history of early
childhood neglect/abuse. Childhood abuse in humans is associ-
ated with decreased hippocampal volume, as well as with cognitive
impairments [9]. This influence of childhood adversity and
epigenetic aberrations later in life supports the hypothesis that,
similar to what was observed in rodents [19,20,40], early
childhood events in humans alter epigenetic markings in the
brain. It is tempting to speculate that epigenetic processes mediate
effects of social adversity during childhood on the brain that persist
into adulthood and are known to enhance suicide risk [41,42].
Epigenetic differences might be driven by genetic differences as
well as by other environmental and dietary factors. All suicide
subjects in our study displayed the same genomic sequence in the
rRNA promoter region examined. Additional genetic polymor-
phisms in other regions of the rRNA gene, including among
individual rRNA gene clusters, may play a role in rRNA function.
The structure and length of rRNA gene clusters varies between
individuals [43,44], however, the relationship between rRNA
promoter methylation or rRNA expression and this additional
level of organizational complexity in rRNA is less clear. Genetic
abnormalities in rRNA gene cluster organization are associated
with increased rRNA methylation during cellular senescence [45].
However, the lack of difference between groups in the cerebellum
argues against such genetic differences among these individuals.
Another factor that may influence the methylation status of
individuals is medication prescribed in the treatment of psychiatric
disorders. The mood stabilizing effect of sodium valproate, a
potent histone deacetylase (HDAC) inhibitor known to indirectly
influence DNA methylation [46,47] via chromatin modification
and used in the treatment of bipolar disorder, and the noted
antidepressive effect of S-adenosyl methionine, a methyl donor in
the DNA methylation reaction and an inhibitor of active
demethylation [48] , suggest a role for DNA methylation in mood
regulation [49]. Although none of the subjects in the present study
had been treated with these pharmacological agents, the possibility
of epigenetic regulation by other pharmacological interventions
should not be discounted. Our data do not exclude these
alternative hypotheses.
Figure 5. Anatomical and Genomic specificity of rRNA hypermethylation. Average percentage of rRNA promoter methylation for selected
subjects with large methylation differences in the hippocampus (A) and in the cerebellum (B) of suicide subjects (N=4, black bars) and controls
(N=4, white bars) for the same subjects. Data are expressed as mean 6 S.E.M. **, P,0.01, measured by unpaired t-test. (C) Multiple regression
analysis shows a similar negative relationship between the number of methylated CpGs per clone and the number of clones in cerebellum samples
from suicide subjects (20 clones64 subjects, N=80 total clones; filled circles) and controls (20 clones64 subjects, N=80 total clones; open circles).
There are 26 circles per group, as clones are grouped according to methylation status. (D) (above) Representative images of genome-wide
methylation in the hippocampus for a suicide subject and a control, showing cytosine (C) and 5-methylcytosine (5 mC) content used for nearest
neighbor analysis. (below) Quantification of the percentage of methylcytosine, following the formula: [(5-methylcytosine)6100]/(5-methylcytosine +
cytosine), shows no difference between suicide subjects (N=13, black bar) and controls (N=11, white bar) in genome-wide levels of methylation
(P.0.05), measured by unpaired t-test.
doi:10.1371/journal.pone.0002085.g005
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methylation of the rRNA promoter as well as decreased rRNA
gene expression in suicide subjects. The results of the psychological
autopsy suggest a developmental origin, however, at time this is
speculation based on samples that differ along a wide range of
experiential and potentially genetic dimensions. To date, our data
are merely consistent with the hypothesis that early life events can
alter the epigenetic status of genes that mediate neural functions,
and thus contribute to individual differences in the risk for suicide.
Materials and Methods
Subjects and Sample Preparation
Hippocampal samples obtained from the Quebec Suicide Brain
Bank included: 13 suicide subjects and 11 controls matched for
post-mortem interval (PMI), gender, and age (Table 1). Cerebel-
lar samples were also obtained for 4 of the same suicide subjects
and 4 of the same controls as those used for hippocampal analysis.
An additional 6 hippocampal samples consisting of 5 suicide
subjects and 1 control were also obtained from the Quebec Suicide
Brain Bank for RNA expression analysis, to compensate for the
removal of 5 subjects (2 suicide and 3 controls) due to low RNA
quality. All samples were from male suicide and control subjects of
French-Canadian origin that were processed as previously
described [50]. Samples were dissected at 4uC and stored in
plastic vials at 280uC until analysis. All samples were processed
and analyzed blind to demographic and diagnostic variables.
Possible confounders that were examined included PMI, brain pH,
and age at death of the donor (Table 1). This study was approved
by our local Institutional Review Board and signed informed
consent was obtained from next of kin.
To be included in this study, all subjects had to die suddenly,
with no medical or paramedic intervention. Suicide as the cause of
death was determined by the Quebec Coroner’s Office. Psychi-
atric diagnoses were obtained by means of the SCID I [51] and
SCID II [52] interviews adapted for psychological autopsies,
which is a validated method to reconstruct psychiatric history by
means of extensive proxy-based interviews, as outlined elsewhere
[41]. In addition, to be considered in this study, all suicide subjects
and none of the controls had to have a positive history of
childhood abuse or severe neglect, as determined by structured
interviews using the Childhood Experience of Care and Abuse
(CECA) [53] questionnaire adapted for psychological autopsies, as
described elsewhere [54].
Genotyping of the rRNA promoter region
Genomic DNA was extracted (DNeasy, Qiagen) according to
the manufacturer’s protocol. Primers for PCR were directed
against the rRNA gene promoter (Genebank accession number
U13369) using the following sequences: 59-GTG TGT CCC GGT
CGT AGG-39; antisense: 59-GTC ACC GTG AGG CCA GAG-
39. Primers were selected on the basis that they covered a 400bp
region that included the region selected for sodium bisulfite
analysis, including the regions covered by sodium bisulfite primers.
The resulting PCR products for each subject were sequenced
bidirectionally using the forward and the reverse primer on an ABI
3100 genetic analyzer (Applied Biosystems) and following the
manufacturer’s instructions. Genetic variation was assessed
throughout the rRNA promoter region used for bisulfite analysis
by alignment of genomic DNA with the previously published
rRNA gene promoter sequence using freely available software
(CLC Workbench, CLC bio).
Figure 6. rRNA expression is downregulated in suicide. (A) Suicide subjects (N=16, black bar) showed significantly less rRNA expression than
controls (N=9, white bar); Data expressed as mean 6 S.E.M. *, P,0.05, measured by unpaired t-test. (B) Among subjects where both methylation and
expression of rRNA were analyzed, the correlation between rRNA promoter methylation percentage and expression showed a trend for an inverse
relationship between methylation percentage and expression of rRNA in suicide subjects (N=11, filled circles) and controls (N=8, open circles).
doi:10.1371/journal.pone.0002085.g006
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Genomic DNA was extracted (DNeasy, Qiagen) and sodium
bisulfite conversion of genomic DNA was performed as previously
described [55,56] for 13 suicide subjects and 11 controls for
hippocampal samples and for 4 suicide subjects and 4 controls for
cerebellum samples. Primers for PCR were directed against the
rRNA gene promoter using the following sequences: sense: 59-GTT
TTT GGG TTG ATT AGA-39;a n t i s e n s e :5 9-AAA ACC CAA
CCT CTC C-39 [32]. Because the primers did not contain CpG
dinucleotides, methylated and unmethylated sequences amplified
with equal efficiency. The resulting product was excised, purified,
subcloned, and transformed (TA cloning kit, Invitrogen). Individual
cloneswereextractedandsequenced(CEQ8800,Beckman-Coulter)
according to the manufacturer’s protocol. Twenty clones were
sequenced for each subject from 2 to 3 independent PCR reactions.
To ensure that the bisulfite conversion was complete, only clones in
which all cytosine residues in non-CpG dinucleotides had been
converted to thymidine were included in the analysis.
Nearest Neighbor Quantification of Methylated Cytosine
Content
Genome-wide levels of 5-methylcytosine were quantified as
previously described [57]. Briefly, genomic DNA from the same
subjects as those used for bisulfite analysis was subjected to MBoI
restriction enzyme digestion (recognition sequence: NGATCN),
incubated with a
32P-labelled oligonucleotide, loaded onto TLC
phosphocellulose plates, and separated by chromatography.
Reactions were repeated in triplicate. The intensities of 5-
methylcytosine and cytosine spot densities were analyzed using a
PhosphoImager screen followed by Image Quant image analysis.
For each subject, levels of methylated cytosine were tabulated as a
percentage of total cytosine content, following the formula: [(5-
methylcytosine) 6100]/(5-methylcytosine + cytosine).
RNA Extraction and Quantitative Reverse Transcription
PCR (qRTPCR) of rRNA Gene Expression
RNA extraction was performed using Trizol (Invitrogen)
followed by Dnase I treatment, and cDNA conversion was
performed using random hexamer primers (Invitrogen) according
to the manufacturer’s instructions (Roche Molecular Biochemi-
cals). The subjects were the same as those used for the bisulfite
mapping study, however, RNA samples from subjects with RNA
Integrity Numbers (RINs) lower than 5.0 or brain pH less than 6.0
were excluded from analysis (N=2 suicide subjects and N=3
control subjects), consistent with previously described criteria for
exclusion [50]. Because of the low number of remaining subjects
and preliminary data indicating a trend for lower rRNA
expression in the suicide subjects used for bisulfite analysis, we
included an additional 5 suicide subjects (total N=16) and 1
control subject (total N=9) for rRNA expression analysis. Primers
were directed against the rRNA gene using the following
sequences: sense; 59-TTC TCT AGC GAT CTG AGA GGC
GT-39, antisense; 59-TAC CAT AAC GGA GGC AGA GAC
AGA-39 and GAPDH (Genebank accession number NM_002046)
using the following sequences: sense; 59-GAA GGT GAA GGT
CGG ACT C-39, antisense; 59-GAA GAT GGT GAT GGG ATT
TC-39. A master mix, containing the cDNA, 10 mM Tris-Cl,
50 mM KCl, 2.0 mM MgCl2, 0.2 mM dNTPs, 5X SYBR Green
I Solution, HotStart Taq DNA polymerase (Superarray Bioscience
Corporation), and 0.2 mM of the sense and antisense primers, were
loaded into LightCycler capillaries (Roche Molecular Biochemi-
cals). For the rRNA gene, the qRTPCR protocol (LightCycler
Software 3.5, Roche Molecular Biochemicals) consisted of initial
HotStart Taq DNA polymerase activation cycle (15 min, 95uC,
with a temperature transition rate of 20uC/sec) followed by 36
cycles of denaturation (30 sec, 95uC, with a temperature transition
rate set at 20uC/sec), annealing (30 sec, 55uC, with a temperature
transition rate set at 20uC/sec) and elongation (30 sec, 72uC, with
a temperature transition rate set at 20uC/sec). A single
fluorescence reading was acquired at the end of each elongation
step. Subsequently, the PCR products were melted using the
following program: 95uC with a temperature transition rate of
20uC/sec, 65uC, with a temperature transition rate of 20uC/sec
followed by 95uC, with a temperature transition rate of 0.1uC/sec.
The presence of a single melting peak followed by analysis on
1.5% agarose gel confirmed product specificity. For the GAPDH
gene, the above procedure was identical except for annealing
temperatures of 51uC and 61uC during the PCR and melting
steps, respectively. Reactions were repeated in triplicate. Reactions
were also carried out in the absence of reverse transcriptase to
verify the absence of genomic DNA contamination. To determine
the relative concentrations of rRNA gene expression, a standard
curve of 10-fold serial dilutions of a mixture of each of the sample
cDNA was used to plot the relative Ct value for each gene on the
y-axis and the amount of cDNA used on the x-axis. To calculate
the fold-change, the relative amount of rRNA product was divided
by the relative amount of GAPDH for each subject.
Statistical Analyses
Statistical analyses were carried out using Statview (Cary, NC).
For DNA methylation analysis, a factorial ANOVA was carried
out with the percentage of methylation as the dependent variable
and group (suicide subjects and controls) as the between groups
factor. The data were then subjected to Bonferroni Post-hoc
analysis to examine methylation status between groups across all
CpG sites. A standardized effect size and associated 95%
confidence interval of the methylation differences between suicide
subjects and controls was calculated for each CpG site using the
difference between group means divided by a pooled standard
deviation corrected for bias, according to previously described
methods [58,59]. The analysis of the relationship between DNA
methylation at each CpG site between suicide subjects and
controls was conducted using linear regression, as were analyses of
the relationships between DNA methylation, expression, PMI,
brain pH, and age. To identify possible diagnostic variables
influencing methylation status, factorial ANOVA followed by
Bonferroni Post-hoc comparisons were used to compare groups of
subjects with different clinical diagnoses. For nearest neighbor as
well as rRNA expression analysis, unpaired t-tests were used to
examine differences between the suicide and control groups. Data
from these statistical analyses are presented as mean 6 SEM.
Statistical significance was determined at P#0.05.
Supporting Information
Figure S1 The published rRNA promoter sequence U13369 is
followed by the sequencing results for each subject for the region
examined by sodium bisulfite mapping. The base pair length of
each sequence is listed on the right side and the consensus
sequence at the bottom of the sequencing results.
Found at: doi:10.1371/journal.pone.0002085.s001 (0.38 MB
PDF)
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